C. Verbeke

Identification of tumour regression in neoadjuvantly treated pancreatic cancer is based on divergent and nonspecific criteria
20242 citationsauthor #5
Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis
202324 citationsauthor #8
Short-course neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer: A multicenter randomized phase-II trial (NORPACT-1).
202331 citationsauthor #16
Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma
202212 citationsauthor #2
Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1)
202221 citationsauthor #29
Tumour Size and T-Stage in Pancreatic Cancer Resection Specimens Depend on the Pathology Examination Approach
20225 citationsauthor #3
Prognostic Impact of Resection Margin Status on Distal Pancreatectomy for Ductal Adenocarcinoma
202210 citationsauthor #2
Paraduodenal pancreatitis – problem in the groove
20229 citationsauthor #10
Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma
202120 citationsauthor #2
ASO Visual Abstract: Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma
20210 citationsauthor #2
Pathology reporting of margin status in locally advanced pancreatic cancer: challenges and uncertainties.
202115 citationsauthor #2
Scoring of tumour response after neoadjuvant therapy in resected pancreatic cancer: systematic review.
202126 citationsauthor #5
Gene expression profiling of morphologic subtypes of pancreatic ductal adenocarcinoma using surgical and EUS-FNB specimens.
202110 citationsauthor #2
Gross Evaluation and Histopathology
20211 citationsauthor #2
Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence
202120 citationsauthor #8
Genome-wide transcriptome profiling of ex-vivo precision-cut slices from human pancreatic ductal adenocarcinoma
20200 citationsauthor #5
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy
202049 citationsauthor #31
Other Cystic Lesions
20201 citationsauthor #2
Serous Cystic Neoplasia
20200 citationsauthor #2
Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma.
202045 citationsauthor #4
DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens.
20209 citationsauthor #7
Immunoglobulin G subtypes-1 and 2 differentiate immunoglobulin G4-associated sclerosing cholangitis from primary sclerosing cholangitis
202012 citationsauthor #9
Acinar Cell Carcinoma
20200 citationsauthor #2
Establishment and Characterization of Paired Primary Cultures of Human Pancreatic Cancer Cells and Stellate Cells Derived from the Same Tumor
20209 citationsauthor #6
The Pancreatic Multidisciplinary Team
20200 citationsauthor #2
Congenital and Developmental Abnormalities
20200 citationsauthor #2
Secondary Neoplasia
20200 citationsauthor #2
Embryology, Anatomy, and Histology
20200 citationsauthor #2
Specimen Dissection and Sampling
20201 citationsauthor #2
Intraductal Papillary Neoplasia
20200 citationsauthor #2
EUS is accurate in characterizing pancreatic cystic lesions; a prospective comparison with cross-sectional imaging in resected cases
202013 citationsauthor #3
Guidelines on the histopathology of chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society,
202059 citationsauthor #3
Endocrine Cell Hyperplasia
20200 citationsauthor #2
Pancreatic Specimen Types
20200 citationsauthor #2
Non-Epithelial Neoplasia
20200 citationsauthor #2
Epithelial Nr5a2 heterozygosity cooperates with mutant Kras in the development of pancreatic cystic lesions
202011 citationsauthor #4
Pancreatoduodenectomy with venous resection for ductal adenocarcinoma rarely achieves complete (R0) resection.
202034 citationsauthor #5
Endocrine Neoplasia
20202 citationsauthor #2
Common Minor Changes
20200 citationsauthor #2
European Guideline on IgG4-related digestive disease – UEG and SGF evidence-based recommendations
2020186 citationsauthor #33
Genome-wide transcriptome profiling of ex-vivo precision-cut slices from human pancreatic ductal adenocarcinoma
202017 citationsauthor #5
Cystic Lesions: Classification and Sampling
20200 citationsauthor #2
Inflammatory Disorders
20200 citationsauthor #2
Ductal Adenocarcinoma
202040 citationsauthor #2
Pancreatic Intraepithelial Neoplasia
20200 citationsauthor #2
Mucinous Cystic Neoplasia
20200 citationsauthor #2
Hereditary Exocrine Disorders
20200 citationsauthor #2
Solid Pseudopapillary Neoplasia
20201 citationsauthor #2
Differential Gemcitabine Sensitivity in Primary Human Pancreatic Cancer Cells and Paired Stellate Cells Is Driven by Heterogenous Drug Uptake and Processing
202020 citationsauthor #3
The Role of Frozen Section
20201 citationsauthor #2
RE: correct reporting is of utmost importance when a controversial treatment is being evaluated.
20190 citationsauthor #5
Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells
201930 citationsauthor #7
RE: Pancreatectomy with arterial resection.
20190 citationsauthor #5
Improved lymph node yield in laparoscopic distal pancreatectomy specimens in patients with pancreatic adenocarcinoma
20190 citationsauthor #3
Kidney Involvement in Patients with Type 1 Autoimmune Pancreatitis
201914 citationsauthor #4
Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer.
2019111 citationsauthor #9
Ex vivo organotypic culture system of precision-cut slices of human pancreatic ductal adenocarcinoma
201977 citationsauthor #8
Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells
201993 citationsauthor #3
Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information
20193 citationsauthor #4
Trends in management and outcome of cystic pancreatic lesions – analysis of 322 cases undergoing surgical resection
201912 citationsauthor #5
Pancreatoduodenectomy with venous resection for pancreatic cancer does not improve the R0-rate
20180 citationsauthor #5
In vitro characterization of different primary and immortalized pancreatic stellate cells
20180 citationsauthor #7
Silencing of caveolin-1 in fibroblasts as opposed to epithelial tumor cells results in increased tumor growth rate and chemoresistance in a human pancreatic cancer model
201819 citationsauthor #3
Pancreatic cancer - summary of the session of 6th International Pancreatic Days in Gdynia 27-30 October 2016.
20181 citationsauthor #1
Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic adenocarcinoma
20181 citationsauthor #3
Pathology assessment of pancreatic cancer following neoadjuvant treatment: Time to move on.
201863 citationsauthor #1
Portal vein reconstruction using primary anastomosis or venous interposition allograft in pancreatic surgery.
201832 citationsauthor #4
Intratumour heterogeneity in pancreatic cancer following neoadjuvant chemotherapy
20180 citationsauthor #1
AB075. P047. Human pancreatic stellate cells secreted fibronectin promote chemoresistance to gemcitabine in PDAC
20180 citationsauthor #3
Targeted Proteomic Analysis of Pancreatic Cyst Fluid Accurately Identifies Cystic Precursors and Forms of Pancreatic Cancer
20170 citationsauthor #3
Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre randomized controlled trial
201793 citationsauthor #9
Development of autoimmune pancreatitis is independent of CDKN1A/p21-mediated pancreatic inflammation
201719 citationsauthor #7
Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC
201742 citationsauthor #12
Operative Specimen Handling and Evaluation of Resection Margins
20175 citationsauthor #1
Can standardized pathology examination increase the lymph node yield following laparoscopic distal pancreatectomy for ductal adenocarcinoma?
20179 citationsauthor #8
Controversies in Pathology Reporting and Staging
20170 citationsauthor #2
The role of Smad7 in pancreatic fibroblasts in modulating cerulein-induced pancreatic fibrosis
20170 citationsauthor #4
Hypoglycemia and decreased insulin requirement caused by malignant insulinoma in a type 1 diabetic patient: when the hoof beats are from a zebra, not a horse
201712 citationsauthor #3
Acute pancreatitis of unknown origin and idiopathic juvenile pancreatitis in Sweden
20170 citationsauthor #10
Highly Accurate Identification of Cystic Precursor Lesions of Pancreatic Cancer Through Targeted Mass Spectrometry: A Phase IIc Diagnostic Study.
201754 citationsauthor #3
Cold-stored cadaveric venous allograft for superior mesenteric/portal vein reconstruction during pancreatic surgery.
201634 citationsauthor #3
Profile of MMP and TIMP Expression in Human Pancreatic Stellate Cells: Regulation by IL-1α and TGFβ and Implications for Migration of Pancreatic Cancer Cells
201651 citationsauthor #5
Superior mesenteric-portal vein reconstruction in pancreatic surgery – comparing reconstruction with cold-stored cadaveric vein allograft versus reconstruction without graft
20160 citationsauthor #4
Dissection of Pancreatic Resection Specimens.
201627 citationsauthor #1
Pancreas epithelial-specific knockout of Smad7 in cerulein-induced pancreatic fibrosis
20160 citationsauthor #5
Pancreatic MRI for the surveillance of cystic neoplasms: comparison of a short with a comprehensive imaging protocol
201678 citationsauthor #7
Morphological heterogeneity in ductal adenocarcinoma of the pancreas - Does it matter?
201667 citationsauthor #1
Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving Landscape
20166 citationsauthor #5
Cerulein-induced pancreatic fibrosis is modulated by Smad7, the major negative regulator of transforming growth factor-β signaling.
201616 citationsauthor #6
Information needs among patients and a surveillance strategy after surgery for pancreatic and periampullary cancer.
20151 citationsauthor #2
Endoscopic papillectomy and KRAS expression in the treatment of adenoma in the major duodenal papilla
201512 citationsauthor #3
Pancreatic MRI for the follow-up of cystic neoplasms: Comparison of a short with a comprehensive imaging protocol
20150 citationsauthor #7
Proteomic Mucin Profiling for the Identification of Cystic Precursors of Pancreatic Cancer
201453 citationsauthor #2
Resection margins in pancreatic cancer: are we entering a new era?
201414 citationsauthor #1
Su1495 Proteomic Studies on Aspirates From Cystic Neoplasms of the Pancreas Provide New Clues to Their Molecular Background and Reveal Novel Biomarker Candidates
20140 citationsauthor #2
Real-Time Assessment of Tissue Hypoxia In Vivo with Combined Photoacoustics and High-Frequency
20140 citationsauthor #4
A matched-pair analysis of laparoscopic versus open pancreaticoduodenectomy: oncological outcomes using Leeds Pathology Protocol.
201444 citationsauthor #2
cells from blood and tonsils during primary infection Integration of apoptosis and telomere erosion in virus-specific CD8+ T
20130 citationsauthor #10
3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing
2013357 citationsauthor #7
The Role of Cytology
20139 citationsauthor #2

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT